Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H30O8 |
Molecular Weight | 494.533 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@@]3(C)[C@@H](C[C@H](OC(=O)C4=CC=CC=C4)C(=O)[C@]3([H])[C@@]1(C)C[C@H](OC2=O)C5=COC=C5)C(=O)OC
InChI
InChIKey=PYDQMXRFUVDCHC-XAGHGKQISA-N
InChI=1S/C28H30O8/c1-27-11-9-18-26(32)36-21(17-10-12-34-15-17)14-28(18,2)23(27)22(29)20(13-19(27)25(31)33-3)35-24(30)16-7-5-4-6-8-16/h4-8,10,12,15,18-21,23H,9,11,13-14H2,1-3H3/t18-,19-,20-,21-,23-,27-,28-/m0/s1
Molecular Formula | C28H30O8 |
Molecular Weight | 494.533 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:22:59 GMT 2023
by
admin
on
Sat Dec 16 15:22:59 GMT 2023
|
Record UNII |
5XN29VGR24
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
11431898
Created by
admin on Sat Dec 16 15:22:59 GMT 2023 , Edited by admin on Sat Dec 16 15:22:59 GMT 2023
|
PRIMARY | |||
|
Herkinorin
Created by
admin on Sat Dec 16 15:22:59 GMT 2023 , Edited by admin on Sat Dec 16 15:22:59 GMT 2023
|
PRIMARY | |||
|
5XN29VGR24
Created by
admin on Sat Dec 16 15:22:59 GMT 2023 , Edited by admin on Sat Dec 16 15:22:59 GMT 2023
|
PRIMARY | |||
|
862073-77-6
Created by
admin on Sat Dec 16 15:22:59 GMT 2023 , Edited by admin on Sat Dec 16 15:22:59 GMT 2023
|
PRIMARY | |||
|
DTXSID30235444
Created by
admin on Sat Dec 16 15:22:59 GMT 2023 , Edited by admin on Sat Dec 16 15:22:59 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Herkinorin is a μ-opioid agonist with more than 100x higher μ-opioid affinity and 50x lower κ-opioid affinity compared to Salvinorin A.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|